Primer Extension Enrichment Reaction (PEER): a new subtraction method for identification of genetic differences between biological specimens by Ganova-Raeva, Lilia et al.
Primer Extension Enrichment Reaction (PEER):
a new subtraction method for identification of genetic
differences between biological specimens
Lilia Ganova-Raeva*, Xinjian Zhang, Fengli Cao, Howard Fields and Yury Khudyakov
Centers for Disease Control and Prevention, National Center for Infectious Diseases,
Division of Viral Hepatitis/Laboratory Branch, Atlanta, GA 30329, USA
Received February 1, 2006; Revised April 20, 2006; Accepted May 8, 2006
ABSTRACT
We developed a conceptually new subtraction
strategy for the detection and isolation of target
DNA and/or RNA from complex nucleic acid mix-
tures, called Primer Extension Enrichment Reaction
(PEER). PEER uses adapters and class IIS restric-
tion enzymes to generate tagged oligonucleotides
from dsDNA fragments derived from specimens
containing an unknown target (‘tester’). Subtrac-
tion is achieved by selectively disabling these oligo-
nucleotides by extension reaction using ddNTPs
and a double stranded DNA template generated
from a pool of normal specimens (‘driver’). Primers
that do not acquire ddNTP are used to capture and
amplify the unique target DNA from the original
tester dsDNA. We successfully applied PEER to
specimens containing known infectious agents
(Hepatitis B Virus and Walrus Calicivirus) and
demonstrated that it has higher efficiency than the
best comparable technique. The strategy used for
PEER is versatile and can be adapted for the identi-
fication of known and unknown pathogens and
mutations, differential expression studies and
other applications that allow the use of subtractive
strategies.
INTRODUCTION
The isolation of unique fragments from complex nucleic acid
mixtures without prior knowledge of their sequence or abund-
ance is technically challenging. The earliest approach to the
identiﬁcation of target nucleic acids of unknown sequence,
which involved direct screening of large libraries, is inefﬁ-
cient and labor intensive (1). In the last decade more robust
techniques have been developed. They can be divided into
two categories: (i) subtractive approaches such as differential
display (2,3), representational differences analysis (RDA) (4)
and its variations (5,6), differential subtraction chain (DSC)
(7), Selective Ampliﬁcation via Biotin- and Restriction-
mediated Enrichment (SABRE) (8), Suppression Subtractive
Hybridization (SSH) (9) and (ii) high-throughput methods
like sequencing-by-hybridization (10), microarrays (11,12)
and massive parallel sequencing (13,14). Integration of sub-
tractive approaches into high-throughput methods (15) can
also be used for the identiﬁcation of unknown sequences.
All subtractive approaches are based on molecular compar-
ison of two specimens: ‘tester’, a specimen that is suspected
to contain the unknown target of interest, and ‘driver’, a
specimen that is a perfect genetic match for the tester but
is believed not to contain the target. Subtractive methods
are often used in molecular studies because of their relative
simplicity and high efﬁciency. Among the subtractive
techniques, RDA and the closely related SSH are the most
popular and have been successfully used to recover unknown
sequences. SSH can enrich a target gene  3 · 10
3 (1,9) and
was used to ﬁnd a new calicivirus in walrus (16); GBV-A
and -B viruses were found by RDA (17,18). Although
impressive, this performance is not sufﬁcient for the detection
of an infectious agent that may be present at only a few
copies in the specimen of interest. Some limitations of the
subtractive approaches are the requirements for perfect
hybridization and an abundance of ideally matched driver,
which makes them intrinsically biased against single-
stranded, low-copy-number molecular species (17,19).
Enrichment of the target of interest is achieved by hybridiza-
tion between long and sometimes heterogeneous population
of DNA fragments (e.g. cDNA generated by random
priming). If present in low numbers, such molecules have lit-
tle chance to form complete hybridization products after
denaturing. The fragment length can also compromise the
speciﬁcity by creating background cross-hybridization. In
addition, many subtraction approaches rely on the presence
of a poly-A tail to generate the starting material and con-
sequently are not suitable when working with DNA or
RNA that is not polyadenylated.
The high-throughput approaches are limited by cost, some
are not suitable for use with small sample volumes and others
require prior knowledge of the target sequence.
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method developed in the current study is a new subtraction
techniques that is built on two novel principles: the use of
tester DNA to generate both PCR primer and template, and
the selective inactivation of primers containing sequences
common to the tester and driver to ensure preferential
ampliﬁcation of templates that contain sequences unique to
the tester.
MATERIALS AND METHODS
PEER outline
A general outline of PEER is presented in Figure 1. Total
nucleic acid (NA) is extracted from a tester and a driver
specimen and used in a modiﬁed SMART cDNA protocol
(Clontech, Palo Alto, CA) to generate double stranded
DNA (dsDNA) with two different sets of primers for the
tester and one set for the driver. The product is referred to
as dsDNA to distinguish it from cDNA since it was generated
from total nucleic acid instead from RNA alone (Figure 1,
A1–A4). Tester 1 dsDNA material is converted into small
fragments by extensive endonuclease cleavage and then
tagged by ligation to a specially designed adapter. The
30 end of the adapter incorporates a recognition site for a
class IIS restriction endonuclease (20). After the ligation
the fragments are cleaved with the IIS enzyme to create oli-
gos with unique sequence at the 30 end derived from the tester
and a 50 end derived from the adapter (Figure 1, B1–B3).
These adapter-tagged oligos are annealed to driver dsDNA
template and extended in the presence of biotinylated
ddNTPs. All oligos that prime a reaction from the driver tem-
plate can acquire biotinylated ddNTP. This event blocks any
further extension and allows the removal of the biotinylated
molecules from the reaction by use of streptavidin-coated
magnetic beads. Primers that share driver sequences are
blocked and removed leaving only primers with unique
sequences that can only be found in the tester (Figure 1,
C1–C3). In the presence of Tester23 dsDNA and dNTPs,
these oligonucleotides can prime an extension reaction from
the fragments unique to the tester (target capture). This step
converts the tagged primers into DNA templates suitable
for PCR ampliﬁcation by oligonucleotides containing only
the adapter sequences or in combination with T2PCR
or T3PCR oligos. The last step in PEER is a standard
PCR ampliﬁcation with primers containing only adapter and
T2PCR/T3PCR sequences that can be used without any
molarity restrictions. The ﬁnal step is expected to generate
collection of fragments of different sizes (Figure 1, D1–D3).
Blocking experiments
To test and optimize the blocking efﬁciency we tested a vari-
ety of polymerases: Vent (exo-) polymerase and Deep Vent
(exo-) polymerase (New England Biolabs, Inc., Beverly,
MA); Tth polymerase and Tﬂ polymerase (Promega,
Madison, WI), Thermo Sequenase  (Amersham Pharmacia
Biotech, Inc., Piscataway, NJ) and Taq Polymerase (Roche,
Indianapolis, IN); and a range of nucleotide concentrations
using pB6 as template and 50 pmol each SK and T7 generic
primers as shown in Figure 2. After 45–55 cycles of extension
in the presence of the ddNTPs-bio, one-ﬁfth of the product
was transferred to a fresh PCR tube, supplemented with
Taq DNA polymerase, buffer and dNTPs to a ﬁnal reaction
volume of 50 ml, and subjected to 35 cycles at conditions
suitable for the ampliﬁcation of the particular insert in this
clone.
Target-capture experiments
We used oligonucleotides AT7 and ASK (Table 1) as capture
primers. They were mixed in a master stock with concentra-
tions 8–16 amol of template (pB6) and 100–500 fmol of pri-
mer (AT7/ASK) to approximate the actual primer: template
ratio expected to be generated from a target of similar size
by the PEER protocol. Serial 2-fold dilutions of the stocks
were subjected to 50 PCR cycles (95 C for 20 s, 45 C for
30 s, 72 C for 60 s). One-tenth of each product was subjected
to a second round of PCR with 100 pmol of adapter primer.
As a positive PCR control, the same template was ampliﬁed
with the generic SK and T7 primers.
dsDNA and PEER product enrichment analysis
All dsDNA products, as generated in step A4 (Figure 1), were
tested for the presence of the desired target by PCR with
virus speciﬁc primers to conﬁrm their initial titers before per-
forming any enrichment procedures, e.g. dsDNA generated
from the serum containing 3.6 · 10
8 IU virus was serially
diluted 10-fold and each dilution was used as a PCR template
with HBV speciﬁc primers. The sensitivity of our modiﬁed
(21) HBV speciﬁc PCR is <10 copies/ml. The same proced-
ure was used for all different serum dilutions.
Spot hybridizations were performed with all dsDNA
materials and PEER products to conﬁrm the presence of the
target of interest and to assess the level of enrichment in the
following manner: 10% of all dsDNA and PEER products
were subjected to serial 2-fold dilutions, denatured, spotted
on positively charged nylon membranes, ultraviolet cross-
linked and probed by Southern hybridization (Roche
DIG-labeling and hybridization kit, sensitivity—100 fg)
with digoxigenin-labeled HBV genome or WCV genome,
respectively. The hybridization was done as described by
the manufacturer and the last stringency wash was at 45 C.
The positive hybridization control was genomic DNA from
the corresponding target virus with known concentration
also spotted in 2-fold serial dilutions. The initial concentra-
tion of the tested products was calculated by measuring
A260. The enrichment was calculated by dividing the amount
of targets found after PEER by the amount found before the
enrichment calculated as percent of the applied DNA.
In addition to the spot hybridization, the dsDNAs
and PEER products were cloned in separate libraries using
pTAdvantage vector (Clontech, Palo Alto, CA) and
Escherichia coli Top 10F0 electrocompetent cells (Clontech).
Up to 2000 clones were randomly isolated and sequenced
from the high titer libraries (3 · 10
8 and 3 · 10
7). Up to
400 clones were isolated randomly from each PEER library
and sequenced. The clones selected for sequencing were sub-
ject to PCR with generic vector primers and the resulting
fragments puriﬁed on BioRobot8000 using the QIAquick 96
PCR Biorobot kit (Qiagen, Inc., Valencia, CA). Sequencing
was done on ABI3100 DNA Sequencer (Applied Biosystems,
Foster City, CA) with Bid Dye v3.1 chemistry. All sequences
e76 Nucleic Acids Research, 2006, Vol. 34, No. 11 PAGE 2 OF 9Figure 1. Primer Extension Enrichment Reaction (PEER). (A) Generation of dsDNA from total Nucleic Acid. (1) Tester NA (white and gray rectangle) is split in
two aliquots and denatured; Driver NA (white rectangle) is denatured as well. (2) Single strands are reverse transcribed (RT) by Super Script RT with three
different primers—AFMmeIN6* for the first Tester aliquot, T2N6 (diagonal fill rectangle) for the second aliquot and D0N6 (red rectangle) for the Driver. (3) The
reverse transcriptase switches templates and copies the annealed SMART primers (SMART technology, Clontech). (4) The RT products are amplified with
Advantage2 Polymerase to yield Tester1 dsDNA with primers AMmeIPCR (black rectangle), Tester23 dsDNA with T3PCR (vertical fill rectangle) and T2PCR
(diagonal fill rectangle) and Driver bio-dsDNA with D0bioPCR biotinylated at the 50 end (red rectangle with red circle). (B) Processing of Tester1 dsDNA.
(1) The DNA is cleaved by a cocktail of restriction enzymes that leave 30 GC protruding ends. (2) The ends are treated with the Klenow fragment of DNA
Polymerase I in the presence of dCTP only and then ligated to AMmeIAdapter. (3) The tagged fragments are cut to uniform size by MmeI to create multiple
AMmeIPrimers. (C) Blocking reaction. (1) AMmeIPrimers generated from Tester1 dsDNA are extended on Driver bio-dsDNA template in the presence of
biotinylated ddNTPs (red circles) and ThermoSequenase . (2) Biotinylated molecules are captured with streptavidin-coated magnetic beads (white crescent with
gray bar) and removed from the reaction. (D) Retrieval of targets of interest from the Tester23 dsDNA. (1) Capture PCR—AMmeIPrimers that were not blocked
and removed in the preceding steps are added to Tester23 dsDNA and in the presence of regular dNTP are annealed and extended to capture the targets of
interest. (2) Regular PCR amplification of the capture products with different primer combinations. Black rectangles, primers AFMmeIN6, AFMmeISMART,
AMmeIPCR, AMmeIAdapter.
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www.ncbi.nlm.nih.gov/blast/Blast.cgi). Enrichment for the
target of interest was calculated by dividing the number
of target clones found and conﬁrmed by sequencing in
the PEER libraries by the number of targets found and
conﬁrmed by sequencing in the 3 · 10
7 tester library prior
to the enrichment.
Test Samples
To represent an RNA virus we used VMK cells infected with
a newly discovered calicivirus (16), walrus calicivirus (WCV,
positive-sense, single-stranded RNA virus with no DNA
stage). VMK cells infected with WCV at 10
2 p.f.u. were
used as tester and non-infected VMK cell culture as driver.
To represent a DNA virus as tester, hepatitis B virus (HBV),
isolate HLD1, derived from an experimentally infected chim-
panzee was used at several dilutions of a 3.36 · 10
8 IU source
serum quantiﬁed by RealArt  HBV LC (diagnostic limit
3.5 IU, ARTUS-Biotech) real-time PCR on LightCycler1.5
(Roche, Indianapolis, IN). A pool of 16 normal blood donor
sera was used as a driver and as a tester diluent. The plasmid
pB6, which contains a 650 bp fragment of WCV cloned in
pTAdvantage (Clontech), was used as a control template
for some preliminary test experiments. The primers designed
for use in this study are listed in Table 1.
PEER protocol
Extraction: Total nucleic acid (NA) is extracted from 100 to
200 ml of serum or cell culture using Masterpure Complete kit
(Epicenter Biotechnologies, Madison, WI) or High Pure viral
nucleic acid extraction kit (Roche) and resuspended in 10 ml
of 10 mM Tris (pH 8–8.5).
Modiﬁed SMART protocol:5ml Of the extracted NA is
reverse transcribed (RT) with SuperScript II (Invitrogen,
Carlsbad, CA) (22). Two RT reactions are performed for
the tester, one using 10 pmol each primer AFMmeIN6 and
AFMmeISMART and the other using 10 pmol primers
T2N6 and T3SMART. Primers D0SMART and D0N6
are used for the driver reaction. Reaction volumes and condi-
tions are described in the SMART cDNA synthesis protocol
(Clontech). After synthesis, the enzyme is heat-inactivated
and the product diluted with 40 ml of TE.
PCR ampliﬁcation:1 0ml Of the RT product is ampliﬁed
with Advantage 2 Polymerase (Clontech) as recommended
in the Smart cDNA protocol and using the corresponding
PCR primers (AMmeIPCR for Tester 1, T3PCR and
T2PCR for Tester 23 and D0bioPCR for the driver) in tri-
plicate reactions under the conditions suggested by the manu-
facturer. The ampliﬁcation parameters are 95 C for 1 min;
(95 C for 3 s, 68 C for 3 min) · 28 cycles. The dsDNA is
puriﬁed on a Qiagen PCR puriﬁcation column (Qiagen,
Inc., Valencia, CA) and eluted in 75 ml of 10 mM Tris (pH 8)
Digestion with restriction endonucleases:7 0ml Of the
Tester 1 dsDNA are digested overnight with HpaII, HinP1I,
AciI (Roche Molecular Biochemicals, Germany), MaeII
(MBI Fermentas Amherst, NY) and TaqI (NEB Ipswich,
MA) using 1 ml of each enzyme and TaqI buffer (NEB) at
37 C. After digestion, the enzymes are heat-inactivated; the
fragments puriﬁed through a QIAquick PCR puriﬁcation
kit and eluted in 55 ml of 10 mM Tris (pH 8).
Klenow treatment: The ends of the fragments are ﬁlled in
with Klenow polymerase (Roche) in the presence of dCTP for
1ha t3 7  C. The enzyme is then heat-inactivated; the reaction
mixture puriﬁed with QIAquick nucleotide removal column
(Qiagen), and the product eluted in 50 ml of 10 mM Tris
(pH 8).
Adapter ligation: Double-stranded adapters are prepared by
mixing the forward (AFMmeI) and reverse (ARMmeIP)
adapter primers (Table 1) at equimolar ratio (200 pmol
each), heating to 96 C for 5 min and slowly cooling to
room temperature. The adapter (200 pmol) is ligated over-
night to 45 ml dCTP-ﬁlled-in Tester 1 fragments. The ligation
products are puriﬁed to remove the T4 ligase and buffer
with QIAquick nucleotide removal column and eluted in
55 ml of 10 mM Tris (pH 8).
MmeI digestion: The ligation products are digested with
5 U MmeI (NEB) for 2 h. The cleaved DNA is resolved in
10% polyacrylamide gel, the resulting 50 bp fragment is
cut out, isolated from the gel with QIAquick gel extraction
kit (Qiagen) and resuspended in 50 ml of 10 mM Tris (pH 8).
Blocking of MmeI-tagged primers:2 5ml Of the fragment is
used as primer with 10 ml Driver bio-dsDNA template in the
presence of 2.5 mM each ddNTPs-bio (Biotin-11-ddNTPs,
NEN  Life Science Products Inc., Boston, MA), 0.025 mM
each dNTPs (Roche) and Thermo Sequenase  (Amersham
Pharmacia Biotech, Inc., Piscataway, NJ). The blocking reac-
tion is carried out as follows: 96 C for 3 min; (95 C for 2 s;
55 C for 20 s; 68 C for 20 s) · 55 cycles. The product is puri-
ﬁed with QIAquick nucleotide removal kit to remove the
excess ddNTPs and eluted in 100 ml of 10 mM Tris (pH 8).
Figure 2. Second-round products of the PEER target-capture experiments.
Oligonucleotides AT7 and ASK were used as capture primers on pB6
template mixed as a master stock at a ratio of 8 amol of template to 500 fmol
of primer. Totally 12 serial dilutions of this stock in a 1 mg/ml solution
of salmon sperm DNA were subjected to 50 PCR cycles (95/20, 45/30 and
72/60 s). For both panels, wells 1 and 16 contain molecular-size markers and
wells 14 and 15 are negative controls. (A) Of each product, 10 ml was
amplified in a second-round PCR with 100 pmol of adapter primer only.
Adapter primer reactions yielded amplification products from as little as
0.063 amol of template with as little as 4 fmol of capture primers. (B) As a
positive PCR control, 10 ml aliquots of the same templates were amplified
with the generic SK and T7 primers. These reactions generated the expected
product throughout the entire range of dilutions. Wells 2–15 are the second-
round products generated on templates from the different template primer
concentrations; starting at 8 amol template and 500 fmol capture primers in
well 2; 4 amol template/250 fmol primers in well 3 and so on.
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heated to 95 C, and 50 ml of streptavidin-coated magnetic
beads were added (SPHERO  Streptavidin Magnetic
Particles from Spherotech, Inc., Libertyville, IL). After
10 min incubation at >60 C, the beads are captured on a
magnet rack (Qiagen) and the supernatant removed to a
fresh tube taking care that in the process the temperature
remains >55 C.
Capture reaction:5 0ml of the supernatant (puriﬁed
non-blocked primers) are used in a 100 ml capture reaction
with 5 ml of the Tester 23 cDNA as template under the
following conditions: 95 C for 2 min; (95 C for 20 s; 45 C
for 30 s; 72 C for 2 min) · 10 cycles; (95 C for 20 s;
52 C for 30 s; 72 C for 2 min) · 30 cycles; 72 C for 7 min.
PCR:5ml Of the capture product is ampliﬁed in a 100 ml
ﬁnal reaction volume with primers AMmeIPCR and
T2PCR, AMmeIPCR and T3PCR, or AMmeIPCR alone
under the following conditions: 95 C for 2 min; (94 C for
10 s; 60 C for 20 s; 72 C for 90 sec) · 30 cycles. The product
is quantiﬁed, cloned and sequenced.
RESULTS
Target-capture experiments
PEER was designed to ﬁnd unknown targets at unknown and
potentially very low concentrations. To challenge this goal,
we conducted experiments aimed at identiﬁng the amount
of target DNA in a mixture that can be found and captured
using low concentrations of oligonucleotides designed
so that the 30-terminal half matches the template and the
50-terminal half cannot be found in the template. We also
conducted experiments to determine whether this template
could be ampliﬁed by only the mismatched portion of
the capture oligonucleotides as described in Materials and
Methods. The controls generated the expected product
throughout the entire range of dilutions (Figure 2), and the
adapter primer reactions (i.e. PCR with primers whose
sequences did not exist in the original template) yielded amp-
liﬁcation products from as little as 0.063 amol of template
(136 copies) and with as little as 4 fmol of capture primers.
Blocking experiments
To ensure that a large number of primers could be success-
fully and speciﬁcally blocked by di-deoxytermination, we
tested a variety of polymerases and a range of nucleotide
concentrations using the pB6 template and 50 pmol each of
SK and T7 generic primers as described above. The best
results, as measured by the absence of product in the reac-
tions to which ddNTPs were added, were achieved with
Thermo Sequenase  (Figure 3). We also observed blocking
by Vent (exo-) polymerase (Promega) and Taq polymerase
(Roche) when the ddNTP: dNTP ratio was 10:1, but Thermo
Sequenase  remained the enzyme of choice because it gave
consistent results under all experimental conditions.
Table 1. Primers used in the PEER study
Primer sequence 50–30 Name Function
MmeI experiments
AATGCAGACACAGAAGGTCCATCCGAC AFMmeI TESTER MmeI adapter forward
P-GGTCGGATGGACCTTCTGTGTCTGC ARMmeIP
a TESTER Mmei adapter reverse
GCTGCAGACACAGAAGGTCCATCCGACNNNNNN AFMmeIN6 TESTER 1 cDNA
GCTGCAGACACAGAAGGTCCATCCGACGGG AFMmeISMART TESTER 1 cDNA
CAGACACAGAAGGTCCATCCGAC AMmeIPCR TESTER 1 cDNA PCR
ACACTAGAGCATGCGTCAAGAGAANNNNNN T2N6 TESTER 23 cDNA
ACACTCCAGGAGGTCAGAAACAACGGG T3SMART TESTER 23 cDNA
ACACTAGAGCATGCGTCAAGAGAA T2PCR TESTER 23 cDNA PCR
ACACTCCAGGAGGTCAGAAACAAC T3PCR TESTER 23 cDNA PCR
AAGCAGTGGTATCAACGCAGAGTANNNNNN D0N6 DRIVER cDNA
AAGCAGTGGTATCAACGCAGAGTACGCGGG D0SMART
a DRIVER cDNA
Bio-AAGCAGTGGTATCAACGCAGAGTA D0bioPCR DRIVER cDNA PCR
BpmI experiments (proof-of-concept)
ACACTCGAGGAGGTCTGGAGIIIIIII PEER1BpmN6 TESTER 1 cDNA
ACACTCGAGGAGGTCTGGAGGG PEER1BpmG TESTER 1 cDNA
AACACTCGAGGAGGTCTGGAG PEER1BpmAF TESTER BpmI Adapter Forward
CTCCAGACCTCCTCGAGTGTG PEER1BpmAR TESTER BpmI Adapter Reverse
GAGCTGTGGTGAGTTGGTTGGAAIIIIIII PEERT7N7 TESTER 78 cDNA
AAGCAGAGGCAGCATTGGAGGG PEERT8G TESTER 78 cDNA
AGCTGTGGTGAGTTGGTTGG PEERT7 TESTER 78 cDNA RCR
AGCAGAGGCAGCATTGGAGG PEERT8 TESTER 78 cDNA RCR
AAGCAGTGGTATCAACGCAGAGTAIIIIIII D0N6 DRIVER cDNA
AAGCAGTGGTATCAACGCAGAGTACGCGGG D0SMART
b DRIVER cDNA
AAGCAGTGGTATCAACGCAGAGTA D0PCRbio DRIVER cDNA PCR
Control primers
AATGCAGACACAGAAGGTCCATCCGACTAATACGACTCACTATAGGG AT7
c PEER control primer
AATGCAGACACAGAAGGTCCATCCGACGAAACAGCTATGACCATGAT ASK
3 PEER control primer
I, 5-nitro indol; N, random base.
aP indicates that the oligo was phosphorylated to improve ligation.
bAccording to the SMART cDNA technology (Clontech, Palo Alto, CA).
cThese primers are not part of PEER but were used to monitor the success of the protocols’ steps using a ‘control’ template as described in Results.
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We conducted initial proof-of-concept experiments using
adapters designed to be compatible with the IIS enzyme
BpmI. As a tester, we used serum (HLD1) obtained from
an experimentally infected chimpanzee with an initial hepat-
itis B virus (HBV) titer of 3.36 · 10
8 IU and as driver and
diluent—pooled human sera from normal blood donors.
After probing a Tester1 dsDNA library with dig-labeled
HBV genome and sequencing we observed that 3.12% of
the clones were from HBV (Table 2). This is consistent
with previously published observations of target clone fre-
quencies observed in cDNA libraries generated by random
ampliﬁcation (9,18). The cloned PEER products obtained
from 100-fold dilution of the tester serum yielded 10.6%
HBV clones, which represents an enrichment of 3.39 · 10
2.
Although this value is high, it did not exceed the efﬁciency
of previously published enrichment methods (1).
The ﬁnal version of the enrichment protocol included a
redesign of the cDNA primers and the adapter to accommod-
ate a recognition site for MmeI, a novel IIS restriction
enzyme (23) that cleaves 20 bp downstream of its recognition
site (24). Digestion with MmeI creates primers with longer
unique sequences at their 30 ends and thus they are expected
to have signiﬁcantly improved primer speciﬁcity. To test
this modiﬁcation, we used the same HBV infected serum
specimen as the model for a DNA virus and VMK cells
infected with WCV at p.f.u. 10
2–10
3 as the model for an
RNA virus. We tested all generated dsDNA material for the
presence of the desired target by dilution PCR with virus-
speciﬁc primers. We were able to conﬁrm the presence
of viral targets in all expected dilutions (Table 2). These
results indicate that we consistently achieved accurate
representation of the viral target in all test scenarios.
Compared with the corresponding starting dsDNA materials,
Figure 3. Primer blocking by di-deoxytermination. Well 1 contains 100 bp molecular-size standard (Roche) for Tfl and DVent (exo-) test sets and is empty for
the rest of the enzyme sets. Wells 2–11 are the same for each enzyme tested and contain PCR product generated after supplementing 20% of the blocking reaction
with fresh Taq and 10 mM dNTPs. Well 2, blocked with 10 mM ddNTPs and 10 mM dNTPs; Well 3, blocked with 10 mM ddNTPs and 5 mM dNTPs;
Well 4, blocked with 10 mM ddNTPs and 1 mM dNTPs; Well 5, blocked with 10 mM ddNTPs and 0.1mM dNTPs; Well 6, blocked with10 mM ddNTPs and
5 mM dATP and dCTP; Well 7, blocked with 10 mM ddNTPs and 5 mM dGTP and dTTP; Well 8, blocked with10 mM ddNTPs; Well 9, no ddNTPs in the
blocking step; Well 10, no dNTPs in the blocking step Well 11, no primers or template.
Table 2. Enrichment for targets of interest by PEER with MmeI Adapters
Tested material Target presence confirmed by
Hybridization
b Sequencing
c
Virus Titer IU PCR titer
a Before (T23) After (PEER) Enrichment
d Before (T23) After (PEER) Enrichment
d
HBV HLD1 3.36 · 10
8 10
8 + NT NA 3.12% (96) NT 4.80 · 10
2
3.36 · 10
7 10
7 + NT NA 2 · 10
 1% (2000) NT na
3.36 · 10
6 10
6 NT NT NA 2 · 10
 2e% 10.60% (122)
f 5.30 · 10
2
3.36 · 10
5 10
5 6.26 · 10
 3% 3.21% 5.12 · 10
2 2 · 10
 3e% 1.00% (200) 5.00 · 10
2
3.36 · 10
3 10
3 4.76 · 10
 5% 0.781% 1.64 · 10
4 2 · 10
 4e% 0.26% (380) 1.30 · 10
4
WCV 7240 1.00 · 10
4 10
3 9.60 · 10
 6% 0.314% 3.27 · 10
4 2 · 10
 4e% 0.89% (112) 4.45 · 10
4
NT ¼ not tested; The tested material column identifies the virus isolate and the used serum titer.
aAliquotsfromthedsDNAmaterialsbeforecloningorenrichment weresubjectedto 10-foldserialdilutionsandthe presenceofthedesiredtargetwasconfirmedby
PCR in all dilutions as indicated (e.g. ·10
5 indicates that the target was amplified from five consecutive dilutions).
bAliquots from the dsDNA materials and PEER products were subjected to serial dilutions, spotted on positively charged nylon membranes and probed with
digoxigenin-labeled fragments from the target virus by Southern hybridization. The detected amount of target DNA is shown as percent of the initial aliquot.
cAliquots of the DNA materials were cloned in E.coli and the clones were isolated and sequenced at random (the number of sequenced clones is in brackets).
dEnrichment was calculated by dividing the values in column ‘After (PEER)’ by the corresponding values in column ‘Before (T23)’; NA ¼ not applicable.
eThe number is extrapolated from the last available value confirmed by sequencing (i.e. 0.2).
fThis experiment was done with BpmI adapter.
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tain between 500- and 32700-fold more target molecules
(Table 2). To obtain another more accurate measure of the
degree of enrichment, we cloned the dsDNA materials and
corresponding PEER products to generate paired before and
after enrichment libraries. The clones were screened again
by hybridization and/or sequencing at random. The sequen-
cing results demonstrated that the enrichment was 5 · 10
2
when the initial titer of the HBV serum was 3.36 · 10
5 IU,
and 1.3 · 10
4 when the initial titer of the HBV serum was
3.65 · 10
3 IU. These numbers agree well with the enrichment
calculated from the data obtained by spot hybridization
(Table 2). The HBV fragments found in the cDNA library
before enrichment came from approximately the 2800–
3100 nt position of the genome, whereas the enriched product
contained fragments that mapped to positions 100–350 nt,
1400–1500 nt and 2000–2150 nt—all in regions with high
occurrences of recognition sites of the restriction enzymes
(AciI, HpaII, Hinp1I, TaqI, MaeII) used to generate the
primers in our enrichment protocol (Figure 1, B1).
Efficiency of PEER in comparison with SSH
We compared the performance of PEER with that of SSH
using WCV isolate 7240 inoculated into VMK cell culture
as a tester and VMK cells alone as a perfect driver. We
were previously successful in isolating and describing
WCV from the same source by SSH. The cDNA materials
and PEER products were treated and screened as described
above for HLD1. We found that 0.89% of the WCV PEER
library clones contained the fragments of interest which trans-
lates into enrichment of 4.45 · 10
4, i.e. more than eight times
greater than the enrichment of 5.31 · 10
3 observed by SSH.
DISCUSSION
PEER exploits unique target sequences by creating primers
from the double-stranded material of interest and then using
an intact aliquot of the material as a template for ampliﬁca-
tion. Unlike the SMART protocol we do not use poly-A pri-
mers and use total nucleic acid in place of RNA as starting
material. The ﬁrst strand of cDNA is instead created with
RT primer that has a random hexamer at the 30 end and the
adapter sequence at the 50 end. The use of SuperScript II
Reverse Transcriptase, a derivative of M-MLV with DNA
Polymerase activity (22), ensures that single-stranded RNA,
DNA or RNA:DNA hybrid will be copied into cDNA and
enter the enrichment process. Once priming sites are gener-
ated on both ends of the fragments the product can be expo-
nentially ampliﬁed by SMART PCR to generate dsDNA. This
approach maintains the correct representation of all nucleic
acids entering the protocol (25) and supplies a renewable
source of the target material. Our initial primer design
(Table 1) included 5-nitro-indol instead of random bases at
the 30 end of the RT primers. In the later primer design the
random bases were favored because we observed a lower efﬁ-
ciency of the PCR step and additional experiments (data not
shown) convinced us that the 5-nitro-indol’s higher afﬁnity to
itself hinders the reaction performance. The PEER protocol
can be modiﬁed for use with other pre-dsDNA/cDNA proced-
ures. DNase/RNase treatment, ﬁltration, ultracentrifugation,
gradient separation, etc. could be recommended depending
on the application.
Once generated, the double-stranded material is converted
into unique oligonucleotides by extensive endonuclease
cleavage (Figure 1, B1) to ensure that the primers will per-
fectly match the unknown template. To digest the dsDNA
into multiple small fragments, we used a cocktail of ﬁve
4-cutter enzymes that have different recognition sites but
all leave GC-50 overhangs. After the digestion, the DNA frag-
ments were treated with Klenow DNA polymerase in the
presence of dCTP to ﬁll in the 50 overhangs with 1 nt. This
step converts the self-complementary 50-GC protrusions
into 50-C overhangs that could ligate only to the synthetic
adapters designed accordingly. To convert these short DNA
fragments into primers that could be recovered and used in
the enrichment protocol, we ‘tagged’ them by ligation to
adapters (Figure 1, B2–B3). In the context of the human gen-
ome (3.2 Gb) (26), 18 nt is the minimum required length (x)
for the creation of a speciﬁc oligonucleotide, calculated by
the formula Nx/4
x < 1, where N is the size of the target.
For a large viral genome (e.g. N ¼ 100 Kb) this minimum
length is reduced to 10 bp. However, if the aim is to distin-
guish a viral genome of that size with the the human genome
as a background, we still need a minimum size of 18 bp to
ensure unique sequence speciﬁcity. The PEER protocol uses
adapters with MmeI site, thus generating primers with 20 bp
of unique sequence derived from the target (Figure 1, B3).
This feature and the fact that the protocol is theoretically
able to generate up to 38 primer tags/1000 bp sequence pro-
vides ample speciﬁcity. The adapter can alternatively incorp-
orate sites for other IIS restriction enzymes. We have already
successfully used adapters with BpmI in our preliminary
experiments. The IIS cleavage allows all cDNA fragments
of various lengths that have acquired adapters to be ‘trimmed’
to a uniform length. This generates a population of molecules
that are suitable for extension reactions at a reasonably nar-
row temperature range. Class IIS endonucleases that leave
50-protruding ends (20) are not suitable for PEER because
they will generate self-blocking primers. Additional steps to
ensure elimination of the background ampliﬁcation and
increase speciﬁcity may include synthesis of the Tester 23
dsDNA in the presence of dUTP and subsequent uracil-N-
glycosylase (UDG) treatment of the primer capture product
(after step D1 in Figure 1).
As established, to ﬁnd a high titer virus (e.g. 10
8) within a
library representing the entire human genome one needs to
only search through  10
2 of the clones since  2–3% of
this library should contain viral sequences, however if the
viral titer is 10
3 one needs to screen 10
7 clones. To circum-
vent exhaustive screening of the low titer tester libraries by
colony hybridization we evaluated the copy number of targets
of interest in the dsDNA by PCR and spot hybridization
instead. A PCR approach, although very reassuring when
used on the dsDNA material prior to enrichment, cannot be
applied on the PEER products because they may not be
comprised of fragments that will contain both priming sites.
To assess the presence of the targets of interest in the
PEER products we did spot hybridizations and from the
corresponding libraries isolated colonies at random and
sequenced them. We believe that the observed higher enrich-
ment values obtained for the lower titer library is attributed
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pool creates close to perfect driver match and thus greater
blocking efﬁciency.
PEER is a conceptually new approach for the subtractive
enrichment of complex nucleic acid mixtures and represents
a novel use for both class IIS restriction enzymes and
di-deoxytermination. The use of the tester to generate both
primers and template for the subsequent PCR steps contrib-
utes to the speciﬁcity and sensitivity of PEER in comparison
with other subtraction approaches. Unlike other known sub-
traction techniques where the selection step involves the
hybridization of long DNA molecules which are eventually
used as PCR templates, the PEER blocking step (Figure 1c)
uses short tester-speciﬁc DNA fragments and through hybrid-
ization and highly speciﬁc enzymatic extension selects the
unique ones for PCR primers. Such hybridization kinetics
are signiﬁcantly less complex than those between long
DNA molecules and this may also contribute to the efﬁciency
of the PEER. In addition, because PEER was designed to cre-
ate normalized re-ampliﬁable double-stranded starting mater-
ial, the method is suitable for use with samples of limited
volume and is very cost efﬁcient, especially when compared
with new high-throughput sequencing methods. We did not
observe loss of integrity of the background DNA, i.e. no
recombination or insertion/deletion events in the sequences
that we have seen. We found some primer multimers
among the clones, but we did not quantify them because
the sequence data were ﬁltered for background/vector/primer
noise prior to analysis. In theory PEER can also allow for
several rounds of enrichment, as do RDA and SSH, i.e. the
ﬁnal PEER product could be digested again with the GC cut-
ter cocktail or any other restriction enzyme combination,
adapter-tagged, cut with MmeI and blocked on the same
driver or even on an alternative driver, depending on the
experimental goals. We have not attempted such experiments.
Although other uses of PEER are beyond the scope of this
study, a review of the strategy identiﬁes steps that can be
modiﬁed to increase the versatility of the technique.
Our ﬁndings demonstrate that PEER is robust, can be
applied to different targets and can detect nucleic acids of
unknown sequence at very low concentrations. In our experi-
ments, PEER was able to detect a fragment of interest at very
low initial concentration, outperformed the commercially
available SSH technique and in the case of the HBV test
target it was successful without the availability of a perfect
driver. Collectively, the data obtained in this study indicate
that PEER is more efﬁcient than any other reported subtract-
ive method in recovering target nucleic acids from complex
mixtures.
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